Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...

In others, they are considered only if eczema symptoms worsen or fail to respond to conservative treatment. These drugs are sometimes used on their own or in combination with other treatments. Topical ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals 12 years and older with eczema ... with the drug, and the warnings ...

H.C. Wainwright launched its coverage of eczema drug developer Corvus Pharmaceuticals (NASDAQ:CRVS) with a Buy recommendation ...

Most people with eczema will respond to corticosteroids or calcineurin inhibitors and will not need a biologic. There are also a number of non-biologic drugs that have been used off-label in the past.

A blockbuster drug is a therapy that generates at least $1 billion in sales. Clarivate’s Drugs to Watch 2025 report includes ...

Moisturising well and using a humidifier are part of the right eczema treatment in winter as the cold weather can trigger a flare-up. The cold air can trigger an eczema flare-up. Image courtesy: ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...